capiton portfolio company Dec Group acquires pharmaceutical aseptic fill-finish expert BAUSCH Germany GmbH

capiton portfolio company Dec Group is pleased to announce the acquisition of the activities of Hainspitz-based BAUSCH Germany, a specialist for the design, manufacture, and supply of high-quality pharmaceutical aseptic fill-finish packaging solutions.

With almost 25 years of experience, BAUSCH Germany has built a reputation as an innovative and reliable partner for pharmaceutical companies around the world, underpinning its value proposition by developing highly customized solutions and delivering exceptional service. Besides its outstanding product portfolio of aseptic processing systems for stable containers such as vials, cartridges, ampoules, bottles, and syringes, BAUSCH Germany is also recognized as a leading manufacturer of aseptic filling machines for IV bags.

Following the acquisition, BAUSCH Germany will operate as a subsidiary of Dec Group under the name DEC Filling Germany GmbH.

Laurent Veuillet, former Vice President of BAUSCH Germany who will lead the new subsidiary, comments “We are very pleased to join forces with the Dec Group and become part of a company that shares our commitment to innovation and customer service. This acquisition will allow us to continue providing our customers with the top-quality aseptic processing equipment they have come to rely on, while also expanding our offerings with Dec’s comprehensive, fully integrated, and novel solutions for aseptic filling particularly in the field of powder dispensing.”

The acquisition fully supports Dec’s strategic approach in further refining its end-to-end process containment solution offering to the pharmaceutical industry, covering every production step from molecule to final dosage form and ensuring a seamless flow through each production stage. By combining BAUSCH Germany’s extensive liquid filling know-how and established reputation with Dec’s state-of-the-art containment and unique powder dispensing technologies, the combined group reinforces its expertise and position as an integrated and leading supplier of innovative aseptic filling solutions.

“Our enhanced technological capabilities and BAUSCH Germany’s long-standing expertise will allow us to offer our customers high-grade solutions, aseptic filling lines housed in customized process isolators and containment systems, that ensure safe and controlled operations. We look forward to this new chapter of the Dec Group, as it presents us with opportunities for further growth and success in the global aseptic processing industry.” said Yves Dietrich, Group Managing Director of Dec.

Alexander Zamora, Partner at capiton, added: “We are extremely excited to continue supporting Dec in its successful growth path in becoming the leading provider of end-to-end process containment technologies and look forward to Dec extending its process coverage also to the highly attractive pharmaceutical aseptic filling segment.”

Sellers and buyers have agreed not to disclose the financial terms of the transaction. Dec was advised by Lupp+Partner (Legal), FTI Andersch (Financial), and EY (Tax).

_______________

About capiton AG

capiton is an independent, owner-managed private equity firm that manages a total fund volume of €1.6 billion. The investment portfolio of capiton AG currently comprises 19 medium-sized companies. As an equity partner, capiton supports management buy-outs and growth financing in established medium-sized companies.

www.capiton.com

 

Cookie Consent Banner von Real Cookie Banner